Skip to main content
SpringerLink
Log in

Hepatitis C among drug users: consensus guidelines on management in general practice

  • Original Paper
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Background

Hepatitis C (HCV) is a common cause of morbidity among patients who attend general practitioners (GPs) in Ireland for methadone maintenance treatment.

Aims

To describe the development and content of guidelines for the management of HCV among current or former opiate users in the Eastern Regional Health Authority area attending GPs for methadone treatment.

Methods

The guidelines were produced in five stages: identification of key stakeholders; development of evidence-based draft guidelines; discussion of content; determination of ‘Delphi’-facilitated consensus and review by a sample of GPs for whom the guidelines would be intended.

Results

The guidelines contain advice for GPs on all aspects of care of patients at risk of HCV, including general and preventative care, care of other bloodborne and hepatotoxic viruses, and the factors to be considered and appropriate evaluation prior to referring a patient for assessment at a hepatology unit.

Conclusions

GPs have an important role to play in the care of patients at risk of, or Infected with, HCV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allwright S, Bradley F, Long J et al. Prevalence of antibodies to hepatitis B, hepatitis C and HIV among Irish prisoners: results of a national cross sectional survey.Br Med J 2000; 321: 78–82.

    Article  CAS  Google Scholar 

  2. Smyth R, Keenan E, O’Connor J. Bloodborne viral infection in Irish injecting drug users.Addiction 1998; 93 (11): 1649–56.

    Article  CAS  PubMed  Google Scholar 

  3. Prevalence of HCV among drug users attending general practice. Association of University Departments of General Practice Annual Scientific Meeting; 2000 July; Bournemouth.

  4. Wong J, McQuillan G, McHutchinson J, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States.Am J Pub Health 2000; 90 (10): 1562–9.

    Article  CAS  Google Scholar 

  5. Keenan E, Barry J. Managing drug misuse in general practice.Br Med J 1999; 319: 1497.

    CAS  Google Scholar 

  6. Woolf S, Grol R, Hutchinson A. Clinical guidelines: potential benefits limitations and harms of clinical guidelines.Br Med J 1999; 318: 527–30.

    CAS  Google Scholar 

  7. Gerlach FM, Beyer M, Berndt M et al. [The DEGAM-concept-development, dissemination, implementation and evaluation of guidelines for general practice].Z Arztl Fortbild Qualitatssich 1999; 93 (2): 111–20.

    CAS  PubMed  Google Scholar 

  8. Desirable attributes of clinical practice guidelines. Washington: Institute of Medicine. National Academy Press, 1992.

  9. Conroy M, Shannon W. Clinical guidelines: their implementation in general practice.Br J Gen Prac 1995; 45 (396): 371–5.

    CAS  Google Scholar 

  10. Onion CW, Dutton CE, Walley T, Turnbull CJ, Dunne WT, Buchan IE. Local clinical guidelines: description and evaluation of a participative method for their development and implementation.Fam Pract 1996; 13(1): 28–34.

    Article  CAS  PubMed  Google Scholar 

  11. Jones J, Hunter D. Consensus methods for medical and health services research.Br Med J 1995; 311: 376–80.

    CAS  Google Scholar 

  12. Broomfield D, Humphris G. Using the Delphi technique to identify cancer education requirements of general practitioners.Med Edu 2001; 35 (10): 928–37.

    CAS  Google Scholar 

  13. Guidelines on the management of hepatitis C in general practice: a semiqualitative interview survey of GPs’ views regarding content and implementation. Joint Symposium of the Society for the Study of Addiction and the Faculty of Substance Misuse of the Royal College of Psychiatrists; 2002; Leeds, UK

  14. MacDonald M, Wodak. Preventing transmission of hepatitis C.Australian Fam Phys 1999; 28 (Special Issue 15): 14–7.

    Google Scholar 

  15. Management of hepatitis C.NIH Consensus Statement 1997; 15 (3): In press.

  16. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors.Epidem Rev 1996; 18 (2): 137–48.

    CAS  Google Scholar 

  17. Dienstag J. Sexual and perinatal transmission of hepatitis C.Hepatology 1997; 26 (Supplement 1): S66-S70.

    Article  Google Scholar 

  18. Consensus Statement. International Consensus Conference on hepatitis C; 1999 26–28 February; Paris. European Association for the Study of Liver Disease (EASL).

  19. Sherman M. Management of viral hepatitis: clinical and public health perspectives — a consensus statement. CASL Hepatitis Consensus Group. Canadian Association for Study of the Liver.Can J Gastro 1997; 11 (5): 407–16.

    CAS  Google Scholar 

  20. Ohto H, Terazawa S, Sasaki N, Hino K, Ishiwata C et al. Transmission of hepatitis C from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group.New Engl J Med 1994; 330: 744–50.

    Article  CAS  PubMed  Google Scholar 

  21. Zanetti A, Tanzi E, Romano L et al. A prospective study on mother to infant transmission of hepatitis C virus. Intervirology 1998; 41: 208–12.

    Article  CAS  PubMed  Google Scholar 

  22. Meisel H, Reip A, Faltus B et al. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin.Lancet 1995; 345: 1209–11.

    Article  CAS  PubMed  Google Scholar 

  23. Thomas D, Villano S, Riester K et al. Perinatal transmission of hepatitis C virus from HIV-1 infected mothers. Women and Infants Transmission Study.J Infet Dis 1998; 177: 1480–8.

    Article  CAS  Google Scholar 

  24. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease.Morbidity and Mortality Weekly Reports (MMWR): 1998: 1–39.

  25. A strategy for the detection and management of hepatitis C in Australia. Canberra: National Health and Medical Research Council (NHMRC). Australian Government Publishing Service, 1997.

  26. Garcia-Samaniego J, Soriano V, Castilla J. Influence of hepatitis C virus genotypes on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.Am J Gastroentol 1997; 92: 1130–4.

    CAS  Google Scholar 

  27. Acharaya S, Dasarathy S, Kumer T et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome.Hepatology 1996; 23 (6): 1447–55.

    Google Scholar 

  28. Fong T, Di Bisceglie A, Waggoner J, Banks S, Hoofnagle J. The significance of antibody to hepatitis C in patients with chronic hepatitis C.Hepatology 1991; 14: 64–7.

    Article  CAS  PubMed  Google Scholar 

  29. Chiaramonte M, Stroffolini T, Vian A. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.Cancer 1999; 85: 2132–7.

    Article  CAS  PubMed  Google Scholar 

  30. Keating S. Vaccination guidelines for patients attending the ERHA drug treatment clinics. Dublin: Eastern Regional Health Authority, 2000.

  31. Immunisation guidelines for Ireland: National Immunisation Committee, Royal College of Physicians of Ireland, 1999.

  32. Immunological responses to hepatitis C and non-hepatitis C antigens in hepatitis C (HCV) and human immunodeficiency (HIV)-HCV coinfected patients. XIII International AIDS Conference; 2000; Durban, South Africa.

  33. Melvin D, Lee J, Belsey E. The impact of co-infection with hepatitis C and HIV on the tolerability of antiretroviral therapy.AIDS Patient Care STDS 2000; 14: 463–85.

    CAS  Google Scholar 

  34. Poles M, Dieterich D. Hepatitis C Virus/Human immunodeficiency virus coinfection: clinical management issues.Clin Infect Dis 2000; 31 (1): 154–61.

    Article  CAS  PubMed  Google Scholar 

  35. Furner V, Ross M. Lifestyle clues in the recognition of HIV infection.Med J Aust 1993; 158: 40–1.

    CAS  PubMed  Google Scholar 

  36. Carne P, Roass M, Kemp R. A practitioner’s guide to HIV testing.Medical Journal of Australia 1993; 158: 267–8.

    CAS  PubMed  Google Scholar 

  37. Kidd M, Cheng W, Wilson S. Initial management of hepatitis C.Aust Fam Phys 1999; 28: SI32–35.

    Google Scholar 

  38. McCoy R, Watson K, Kosky M. A guide to diagnosis.Aust Fam Phys 1999; 28: SI19-SI23.

    Google Scholar 

  39. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups.Lancet 1997; 349(9055): 825–32.

    Article  CAS  PubMed  Google Scholar 

  40. Schiff E. Hepatitis C and alcohol.Hepatology 1997; 26 (3 Suppl 1): 39S-42S.

    Article  CAS  PubMed  Google Scholar 

  41. Harley H, Shaw D, Steven I. Ongoing management of hepatitis C.Australian Fam Phys 1999; 28 (Special Issue): SI36–9.

    Google Scholar 

  42. Ortiz V, Berenguer M, Rayon J, Carrasco D, Berenguer J. Contribution of obesity to hepatitis C-related fibrosis progression.Am J Gastroenterol 2002; 97: 2408–14.

    Article  PubMed  Google Scholar 

  43. Lam N, Pitrak D, Speralakis R et al. Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C.Dig Dis Sci 1997; 42: 178–85.

    Article  CAS  PubMed  Google Scholar 

  44. Davis G, Lau J, Urdea M, et al. Quantitative detection of hepatitis C virus RNA with a solid phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients.Hepatology 1994; 19: 1337–41.

    Article  CAS  PubMed  Google Scholar 

  45. Best D, Lehman P, Gossop M et al. Eating too little, smoking and drinking too much: wider lifestyle problems among methadone maintenance patients.Addiction 1998; 6: 290–1.

    Google Scholar 

  46. RACGP/ANCARD Hepatitis C algorithms.Aust Fam Phys 1999; 28 (SI 71): 72–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Practice, University College Dublin, Coombe Healthcare Centre, Dolphin’s Barn, Dublin 8, Ireland

    Walter Cullen

Authors
  1. Walter Cullen
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Dublin Area Hepatitis C Initiative Group

Corresponding author

Correspondence to Walter Cullen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dublin Area Hepatitis C Initiative Group., Cullen, W. Hepatitis C among drug users: consensus guidelines on management in general practice. Ir J Med Sci 173, 145–150 (2004). https://doi.org/10.1007/BF03167929

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03167929

Keywords

Search

Navigation